Recently, at the 2025 InnoMatch Global Tech-Matching Fair, the "2025 China Biopharmaceutical Technology Innovation Value Ranking of Huayi List" was officially unveiled. Biokin Pharmaceutical was selected as one of the "Top 10 Most Influential Biopharmaceutical Companies" for its groundbreaking biopharmaceutical innovations.

This event was co-hosted by the Ministry of Science and Technology of the People's Republic of China and the Shanghai Municipal People's Government, guided by the National Biopharmaceutical Enterprise Platform, and initiated by Yiyun Tech and the National Eastern Tech-Transfer Center. It aimed to recognize leading enterprises in the industry that boast core technological competitiveness and industrial transformation potential.

About the Biopharmaceutical Ranking

The ranking primarily focuses on domestic companies with biopharmaceutical innovation pipelines and leading in research and development progress.

Chinese biopharmaceutical companies have transitioned from being "Fast Followers" to "Global Innovators," whose R&D capabilities, pipeline depth, and market value have received high recognition from top global pharmaceutical companies. The companies selected for the "Top 10 Most Influential Biopharmaceutical Companies" represent the leading forces in China's biopharmaceutical industry and remarkable accomplishments in areas such as antibody drugs (bispecific antibodies/ADCs), fusion proteins, and platform technologies.